INTERNATIONAL FACULTY

Dr Mikael Ryden, Sweden

Mikael Rydén is Professor of Clinical and Experimental Adipose Tissue Research at Karolinska Institutet. He heads the Center for Clinical Metabolic Research in Diabetes and the Endocrinology Unit, and chairs the Strategic Research Programme in Diabetes at Karolinska Institutet and Umeå University. He also serves as Senior Consultant in Endocrinology and Diabetology at Karolinska University Hospital, Stockholm, Sweden. His research focuses on the role of human adipose tissue in a broad spectrum of physiological and pathological conditions, ranging from advanced cellular and molecular studies in experimental models to clinical investigations in humans. In recognition of his contributions to the field, he received the 2025 EASD Camillo Golgi Award. He served as Honorary Secretary of the EASD from 2018 to 2022 and is currently Vice-Chair of the EASD Committee for Clinical Affairs, with his term as Chair commencing in 2027. He is also a member of the Nobel Assembly at Karolinska Institutet.

Dr Johanna Brix, Austria

Dr Johanna Brix is an Austrian physician specialising in internal medicine, with subspecialties in endocrinology, diabetology, and nephrology. She serves as a senior consultant at the 1st Medical Department of the Klinik Landstraße in Vienna, where she heads the Obesity Clinic and the Diabetes Centre Wienerberg. Her clinical focus encompasses comprehensive care for patients with diabetes and obesity, integrating advanced therapies such as insulin pump management and continuous glucose monitoring.

Prof Dr Leszek Czupryniak, Warsaw, Poland.

Prof Leszek Czupryniak is a specialist in medicine and dibetology and has been working as Head of the Department of Diabetology and Internal Diseases and the Medical University of Warwas. He graduated from the Medical University of Lodz in 1994, and had further training at Oxford, London and Wakefield(Great Britain), Maastricht(Netherlands), and Miami(USA). His areas of interest are type 1 diabetes, type 2 diabetes, diabetes accompanying other diseases, and chronic complications of diabetes, with special interest in oral antidiabetic agents and insulins.

Dr. David Strain, UK

Dr David Strain is a Senior Clinical Lecturer at the University of Exeter Medical School, with an expertise in microvascular structure and function. Clinically, he runs a community service for the older adult with diabetes and/or cardiovascular disease, and works as an in-patient consultant

His main focus is the health of older adults with diabetes; ensuring the right patient gets the right treatment. This includes research exploring the mechanism that some medications, specifically the SGLT-2 inhibitors and GLP-1 analogues, give benefits for people with diabetes, heart disease and renal failure beyond their effect on sugar and blood pressure. The hope is we can identify those who would benefit most before arising. He has performed the only study to date demonstrating the feasibility of individualizing targets for older adults across Europe. This has informed the new UK NICE guidance document.

Since April 2019, he has also been running a COVID service as clinical lead in COVID for Exeter, been involved in the national Long COVID taskforce, and establishing research into the underlying causes and potential cures.

Dr Adi E Mehta

Dr. Adi E Mehta is a graduate of University of Western Ontario and completed his Endocrinology fellowship at McGill University in Montreal, Canada. After working at University of Manitoba in Winnipeg as an Assistant and subsequently Associate Professor, he moved to the USA and joined the faculty at the Cleveland Clinic in the Department of Endocrinology. He is a member of numerous societies in both the USA and Canada and is listed in "Best Doctors in America: 2003-2004 and 2005-2006. He was awarded the Outstanding Clinical Endocrinologist Award for the year 2009 by the American Association of Clinical Endocrinologists. Dr. Adi E Mehta is a graduate of University of Western Ontario and completed his Endocrinology fellowship at McGill University. He later joined Cleveland Clinic USA.